Worldwide reporting of TB cases declined during the pandemic due to lockdowns, social distancing and COVID’s disruption of the healthcare system. Now, TB experts are bracing for a surge of the disease, which, due to improved diagnostics and treatments, had been targeted for global control within 15 years.

Researchers discover an important new way to compare the effectiveness of tuberculosis treatments that will have crucial implications for combatting the global tuberculosis epidemic. This research is led by scientists at the University of Colorado Anschutz Medical Campus, Colorado State University and University of California San Francisco.